Transcriptome-wide identification of 5-methylcytosine by deaminase and reader protein-assisted sequencing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40197347.
- Also identified by DOI 10.7554/eLife.98166 and PMC identifier 11978299.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
5-Methylcytosine (m<sup>5</sup>C) is one of the posttranscriptional modifications in mRNA and is involved in the pathogenesis of various diseases. However, the capacity of existing assays for accurately and comprehensively transcriptome-wide m<sup>5</sup>C mapping still needs improvement. Here, we develop a detection method named DRAM (deaminase and reader protein assisted RNA methylation analysis), in which deaminases (APOBEC1 and TadA-8e) are fused with m<sup>5</sup>C reader proteins (ALYREF and YBX1) to identify the m<sup>5</sup>C sites through deamination events neighboring the methylation sites. This antibody-free and bisulfite-free approach provides transcriptome-wide editing regions which are highly overlapped with the publicly available bisulfite-sequencing (BS-seq) datasets and allows for a more stable and comprehensive identification of the m<sup>5</sup>C loci. In addition, DRAM system even supports ultralow input RNA (10 ng). We anticipate that the DRAM system could pave the way for uncovering further biological functions of m<sup>5</sup>C modifications.
Medical subject headings
- 5-Methylcytosine
- Transcriptome
- APOBEC-1 Deaminase